| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/21/2008 | WO2008099969A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
| 08/21/2008 | WO2008099942A1 Plant with deletion of single heterogeneous plant-origin chromosome and method of constructing the same |
| 08/21/2008 | WO2008099898A1 Transglutaminase having disulfide bond introduced therein |
| 08/21/2008 | WO2008099561A1 Agent for promoting cell proliferation using antimicrobial peptide and method for promoting cell proliferation using serum-free medium containing the same |
| 08/21/2008 | WO2008099385A2 Methods and kits for qualifying sperm cells |
| 08/21/2008 | WO2008099185A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 08/21/2008 | WO2008099088A2 Method for the in vitro culture of t cells, in particular t cells infiltrating the so-called til tumours |
| 08/21/2008 | WO2008099006A2 Mitogen independence identifies a highly malignant population of tumor stem cells |
| 08/21/2008 | WO2008098975A1 Truncated alternansucrase coding nucleic acid molecules |
| 08/21/2008 | WO2008098942A2 Process and support structure for the cultivation of living cells |
| 08/21/2008 | WO2008098770A1 Method for providing mature dendritic cells |
| 08/21/2008 | WO2008098366A1 Fibrous scaffold for use in soft tissue engineering |
| 08/21/2008 | WO2008079315A3 Ilcs based pattern recognition of sepsis |
| 08/21/2008 | WO2008063564A9 Isolated myeloid-like cell populations and methods of treatment therewith |
| 08/21/2008 | WO2008021322A3 Selective alpha particle-mediated depletion of tumor vasculature with vascular normalization |
| 08/21/2008 | WO2007146253A3 Methods for the cryopreservation of animal cells that contain high levels of intracellular lipids |
| 08/21/2008 | WO2007140011A3 Erythroid progenitor cells and methods for producing parvovirus b19 therein |
| 08/21/2008 | WO2006138433A3 Induction of cell differentiation by class i bhlh polypeptides |
| 08/21/2008 | WO2005104755A3 Artificial immune system: methods for making and use |
| 08/21/2008 | US20080201806 Tetracycline Repressor and Uses Thereof |
| 08/21/2008 | US20080201804 Protein Production |
| 08/21/2008 | US20080201802 Transgenic plant which expresses linoleic acid desaturase for use in controlling alpha-linolenic acid content in structural lipids or storage oils |
| 08/21/2008 | US20080201799 Protein kinase stress-related proteins and methods of use in plants |
| 08/21/2008 | US20080201798 Transgenic seed for propagation of disease resistant crop plants; biological pest control |
| 08/21/2008 | US20080201791 T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells |
| 08/21/2008 | US20080201790 Method and product for regulating cell responsiveness to external signals |
| 08/21/2008 | US20080201789 Variants and exons of the glyt1 transporter |
| 08/21/2008 | US20080200862 Method To Administer Stem Cells In Combination With One Or More Acoustically Active Materials And Ultrasound Energy |
| 08/21/2008 | US20080200665 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 08/21/2008 | US20080200567 In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders |
| 08/21/2008 | US20080200548 N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with Infertility |
| 08/21/2008 | US20080200523 Derivatives of squaric acid with anti-proliferative activity |
| 08/21/2008 | US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 08/21/2008 | US20080200419 Deletion and frame shift mutation; protecting hematopoietic stem cells from cytotoxic stress; enhancing maintenance in vitro during retroviral transduction; slowing aging; leukemia, solid tumors, genetic disorders |
| 08/21/2008 | US20080200414 HCaRG, A Novel Calcium-Regulated Gene |
| 08/21/2008 | US20080200408 Isolated recombinant nucleic acids; expression constructs; stably transformed or transfected host cells; sodium channel antagonistic analgesic agents; side effect reduction |
| 08/21/2008 | US20080200403 Semi-synthetic 9a-carbamoyl or thiocarbamoyl azalides; use of 15-membered azalides having at the 9a-position a carbamoyl or thiocarbamoyl group; inhibitor of TNF- alpha , IL-1, IL-6, IL-8, IL-2 or IL-5; and inhibitor of excessive lymphocyte proliferation; and excessive granulocyte degranulation |
| 08/21/2008 | US20080200401 Mixing powdered oleander leaf with supercritical carbon dioxide above critical pressure and critical temperature; depressurization and cooling to give a separated extract mixture; recovering cardiac glycoside-containing extract which acts as an antiproliferative agent; solvent extraction |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080200388 Stem cell factor-like proteins and uses thereof |
| 08/21/2008 | US20080200378 KGF polypeptide compositions |
| 08/21/2008 | US20080200369 Inhibiting bystin mediated arrest and promoting autophosphorylation of epidermal growth factor receptor; sperm motility, embryonic stem cell formation, trophoblast formation, neuronal growth |
| 08/21/2008 | US20080199960 Methods for the Delivery of Oligomeric Compounds |
| 08/21/2008 | US20080199959 Method For Cell Culture |
| 08/21/2008 | US20080199958 wide-body cell culture vessel with an inversed frusto-conical or inverted frustum bottom for reduced seed volume and better mixing with less hydro-mechanical stress and greater aeration; High density suspension culture; significant larger culture medium surface area for O2 uptake and CO2 stripping |
| 08/21/2008 | US20080199957 therapeutic or diagnostic agent is covalently coupled to the transport agent, which is poly(2-ethylacrylic acid), poly(2-propylacrylic acid), poly(2-butylacrylic acid); drug delivery of proteins, DNA, nucleotides through endosomal membrane |
| 08/21/2008 | US20080199956 Storage Medium For Cells |
| 08/21/2008 | US20080199955 tissue specimens for histological examinations present in cassettes carried by transport basket; means for changing the order in which two transport baskets pass through the apparatus; pathology |
| 08/21/2008 | US20080199954 differentiating post-mitotic (or post meiotic) eukaryotic and prokaryotic daughter cells due to differences in the cells' DNA, RNA, chromatin associated proteins, or other distinguishable cellular features; Labeling, tagging, or marking; dramatically improve visualization of cellular morphology |
| 08/21/2008 | US20080199953 Securing at least two anchors to the substrate, contacting fibroblasts in growth media to the anchors to attach them and allow them to grow to confluency, and replacing the growth medium with a differentiation medium having a lower serum concentration than the growth medium to induce construct formation |
| 08/21/2008 | US20080199931 Expression vector comprising estrogen signaling protein (IEBP) for use as tool in diagnosis, prevention and treatment of cell proliferative abd bone disorders |
| 08/21/2008 | US20080199917 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines |
| 08/21/2008 | US20080199910 Production of recombinant insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) in transgenic monocots |
| 08/21/2008 | US20080199898 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology |
| 08/21/2008 | US20080199895 Mixture comprising adenosine triphosphatase for use in identifying modulators for treatment and prevention of congestive heart failure |
| 08/21/2008 | US20080199889 Nucleotide sequences coding orphan receptor for use in identifying modulators for prevention and treatment of diabetes |
| 08/21/2008 | US20080199888 Follicle stimulating hormone receptor for use in identifying modulators for prevention and treatment of osteoporosis, menopausal, prostate cancer and polycystic ovary syndrome (PCOS) |
| 08/21/2008 | US20080199883 Protein kinase (PAPAP) for use in diagnosis, prevention and treatment of nervous system disorders |
| 08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
| 08/21/2008 | US20080199849 Using embryonic stem cell culture to generate cardiac, bone and skin grafts; regenerative medicine; tissue engineering |
| 08/21/2008 | US20080199845 Apparatus for preparing blood cells for cold storage |
| 08/21/2008 | US20080199546 Bone growth mixture of quercetin and plant extracts of licorice, ginsengwith bone morphogenic protein gene expression |
| 08/21/2008 | US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures |
| 08/21/2008 | US20080199481 B cell-attracting chemokine 1 specific immunoglobulin for use in treatment and prevention of rheumatoid arthritis |
| 08/21/2008 | US20080199480 Methods for Identifying Risk of Type II Diabetes and Treatments Thereof |
| 08/21/2008 | US20080199476 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 08/21/2008 | US20080199475 Novel glycosylated peptide target in neoplastic cells |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199472 Using secretory leukocyte protease inhibitor (SLPI) to identify modulators for treatment and prevention of tumor migration |
| 08/21/2008 | US20080199471 Optimized cd40 antibodies and methods of using the same |
| 08/21/2008 | US20080199469 Using A20 binding inhibitor of NF- kappa B (ABIN) to stabilize MEK kinase and treat and/or prevent inflammatory diseases |
| 08/21/2008 | US20080199467 Immunoglobulin supergene fusion for use in treatment of vascular disorders |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199463 Method for treating multiple myeloma |
| 08/21/2008 | US20080199461 Using immunoglobulin which preferentially binds cancer specific antigen (OVR110) as treatment for head and neck or endometrial cancer |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
| 08/21/2008 | US20080199450 Acid ceramidase and cell survival |
| 08/21/2008 | US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 08/21/2008 | US20080199443 Bone Morphogenetic Variants, Compositions and Methods of Treatment |
| 08/21/2008 | US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin |
| 08/21/2008 | US20080199441 Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases |
| 08/21/2008 | US20080199440 Injecting suspension of fibrin, collagen, hyaluronic acid and preservative; cosmetic defects |
| 08/21/2008 | US20080199439 Displaces inhibitor of apoptosis proteins (IAP) from caspase; modification of light emission when bound to cell; selectively damages or kills neoplastic cells |
| 08/21/2008 | US20080199437 Lrp4/Corin Dopaminergic Neuron Progenitor Cell Markers |
| 08/21/2008 | US20080199433 Complementing cell lines |
| 08/21/2008 | US20080199432 Role for sry in parkinson's disease |
| 08/21/2008 | US20080199430 Methods and kits for qualifying sperm cells |
| 08/21/2008 | US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide |
| 08/21/2008 | US20080199424 Mart-1 t cell receptors |
| 08/21/2008 | US20080199423 Enhancing apoptosis or cytolytic activity using natural killer cells;ligand polypeptide; interleukins, interferons; anticarcinogen |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | US20080199399 Interfacing Nanostructures to Biological Cells |
| 08/21/2008 | US20080197048 For injured racehorses; kits |
| 08/21/2008 | US20080196173 Novel Laccases, Compositions And Methods of Use |
| 08/21/2008 | DE60037007T2 Angereicherte zentralnervensystem-zellpopulationen Enriched cns-cell populations |
| 08/21/2008 | DE102007008650A1 Zellen zur Therapie des Herzens Cells for the treatment of heart |
| 08/21/2008 | CA2678422A1 Fibrous scaffold for use in soft tissue engineering |
| 08/21/2008 | CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 08/21/2008 | CA2677679A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |